Oncology Drugs Market 2021 - By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Cancer, Thyroid Cancer, Skin Cancer, Bladder Cancer, Cervical Cancer, Blood Cancer), By Drug Class Type (Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/Drug Stores), By Route Of Administration (Oral, Parenteral), And By Region, Opportunities And Strategies – Global Forecast To 2030

aboutimg
Purchase Options
Request Sample
Request For Discount
FAQ
Infoimg

Starting Price : $5000.00 | Pages : 440 | Published : August 2021 | SKU CODE : o&s300 | Format :

Request Sample
Description Table Of Contents Tables & Figures Market Insights Related Reports

Oncology Drugs Definition

The oncology drugs market consists of sales of oncology drugs and related services by entities (organizations, sole traders and partnerships) that produce oncology drugs to diagnose and treat all types of cancers. This industry includes establishments that produce drugs used in chemotherapy, surgery and radio therapies for treating pancreatic cancer, breast cancer, ovarian cancer, gastric cancer, kidney cancer, brain tumor, and other cancer types.

The pharmaceutical industry develops drugs to diagnose, treat or prevent diseases. Pharmaceutical drugs are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy and marketing. Oncology drug manufacturers produce pharmaceutical drugs made from active pharmaceutical ingredients (API) and excipients.

Oncology Drugs Size

The global oncology drugs market reached a value of nearly $160.45 billion in 2020, having increased at a compound annual growth rate (CAGR) of 6.8% since 2015.  The market is expected to grow from $160.45 billion in 2020 to $243.81 billion in 2025 at a rate of 8.7%. The growth is mainly due to rise in incidence of various cancer conditions, increase in popularity of advance therapies (biological and targeted drug therapies), and surge in geriatric population worldwide. The oncology drugs market is expected to grow slightly from $160.45 billion in 2020 to $167.52 billion in 2021 at a CAGR of 4%.  The market is expected to stabilize and reach $243.81 billion in 2025 and $358.45 billion in 2030.  

Growth in the historic period resulted from rapid growth in elderly population, strong economic growth in emerging markets, increased healthcare expenditure, increased number of approvals for hematology/oncology (cancer) drugs, increase in pharmaceutical R&D expenditure and advances in cancer drug discovery. Factors that negatively affected growth in the historic period were patent expiration of drugs, pricing pressures from regulators, challenges due to regulatory changes, and low healthcare access.

Going forward, increase in cancer incidence rate, rise in healthcare expenditure, increasing geriatric population, strong pipeline of drugs and revised FDA regulations to facilitate biologics drug development are expected to drive the market. High costs of drugs, rise in interest rates, rising popularity of alternative therapies and natural remedies, coronavirus pandemic, covid-19 impacting drug trails, and reduction in free trade are major factors that could hinder the growth of the oncology drugs market in the future.

Oncology Drugs Drivers

The key drivers of the oncology drugs market include:

Increasing Geriatric Population

Increasing aging population is expected to increase the prevalence of cancer cases contributing to the growth of the oncology drugs market. The elderly population is increasing rapidly across the world and it is expected to continue over the forecast period. By 2030, the population aged 65 year and above is expected to reach approximately 70 million in the USA. lxxxii By 2050, the percentage of senior citizens in Japan is expected to grow to 40%lxxxiii. According to National Center for Biotechnology Information, about 60% of cancer cases occurs in people with 65 years or older and 75% of deaths caused by cancer in this stage. Thereby, it is considered that cancer is a disease of old age. The expected increase in the aging population suffering from cancer is expected to drive the oncology drugs market.

Oncology Drugs Restraints

The key restraints on the oncology drugs market include:

High Costs of Drugs

High costs associated with drugs is a major issue faced by citizens of many countries. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In less wealthy countries, the lack of cost-effective drugs has influenced the health conditions of the population and has led to a low average life expectancy. For instance, approximately 25% of Americans find it difficult to afford prescription drugs due to high out-of-pocket costs. As a result, in countries such as Chad, Macedonia, Serbia, pharmaceutical companies are faced with the pressure of reducing the price of drugs. The high costs associated with drugs are putting pressure on the revenues of oncology drug manufacturers.

Oncology Drugs Trends

The key trends influencing in oncology drugs market include:

Investment In Artificial Intelligence For Oncology Drugs

Companies in the oncology drugs market are increasingly investing in technologies such as artificial intelligence (AI) to save time and reduce research and development costs. AI is the simulation of human intelligence processes by machines, especially computer systems, which has the potential to surpass human intelligence levels. This technology helps to analyze large sets of chemical and biological data to identify potential drug candidates with higher success rates and at a quicker pace when compared to human analysis. The technology also helps in speeding up the patient recruitment process by matching cancer patients with the most relevant clinical trials, thus lowering clinical trial costs. Major oncology drug manufacturers such as Roche, Pfizer, Johnson and Johnson have already invested in AI technologies to reduce time taken and costs incurred for drug development. For example, Johnson and Johnson have recently entered into an agreement with BenevolentAI, a UK-based start-up, to mine data for designing new oncology drugs.   Similarly, Google is developing an AI microscope program to help pathologists detect cancer. Google’s Augmented Reality Microscope actively analyzes images using Machine Learning algorithms.

CRISPR-Cas9 Technology Use In Cancer Treatment

The development of clustered regularly interspaced short palindromic repeats associated protein 9 (CRISPR-Cas9) technology has shown potential to treat cancer. CRISPR technology can be used to discover the non-coding cancer genome. CRISPR is a family of DNA sequence found in the genomes of prokaryotic bacteria such as archaea. CRISPR-Cas9 changes the DNA sequences and messages by inserting a cut or break in the DNA. CRISPR-Cas9 uses specific proteins to convalesce mutations at genetic level. The technology has entered into clinical trials in the oncology space focused on reprogramming immune cells to the target and destroys tumor cells. CRISPR-Cas9 genome editing reduces the processing associated with the generation of cell line and animal models of cancer and complex generations. It can be employed to promptly engineer oncolytic viruses and immune cells for cancer therapeutic applications. Thus, generates better cancer model for target validation and drug evaluation. CRISPR–Cas9 is accelerating the different stages of oncology drug discovery including target identification, validation and deconvolution, drug synthesis, assessment of drug sensitivity and resistance.

Opportunities And Recommendations In The Oncology Drugs

Opportunities –The top opportunities in the oncology drugs market segmented by type will arise in the blood cancer segment, which will gain $16.2 billion of global annual sales by 2025. The top opportunities in the oncology drugs market segmented by drug class type will arise in the targeted therapy segment, which will gain $44.0 billion of global annual sales by 2025.The top opportunities in the oncology drugs market segmented by distribution channel will arise in the hospital pharmacies segment, which will gain $48.2 billion of global annual sales by 2025. The top opportunities in the oncology drugs market segmented by drug classification will arise in the branded drugs segment, which will gain $76.5 billion of global annual sales by 2025. The top opportunities in the oncology drugs market segmented by route of administration will arise in the oral segment, which will gain $48.7 billion of global annual sales by 2025. The oncology drugs market size will gain the most in the USA at $36.5 billion.

Recommendations-To take advantage of these opportunities, The Business Research Company recommends the oncology drugs companies to consider investing in the development of the cell and gene therapies and microneedle pills, work on strategic alliances for research & development to speed-up the drug discovery and manufacturing process, expanding activities to emerging markets to gain market share, offer competitively priced products to attract the users and use direct-to-consumer (DTC) advertising and big data analytics to reach targeted audience, among other strategies.

Oncology Drugs Segmentation

Oncology drugs market is segmented by type, by drug class type, by distribution channel, by route of administration, by drug classification and by geography.
By Type -
The oncology drugs market is segmented by type into
    • a) Lung Cancer
    • b) Pancreatic Cancer
    • c) Breast Cancer
    • d) Prostate Cancer
    • e) Ovarian Cancer
    • f) Colorectal Cancer
    • g) Gastric Cancer
    • h) Kidney Cancer
    • i) Brain Cancer
    • j) Thyroid Cancer
    • k) Skin Cancer
    • l) Bladder Cancer
    • m) Cervical Cancer
    • n) Blood Cancer
    • o) Others
The blood cancer was the largest segment of the oncology drugs market by type, accounting for 19.4% of the total market in 2020. Going forward, ovarian cancer segment is expected to be the fastest growing segment in the oncology drugs market, at a CAGR of 19.9%.
By Drug Class Type –
The oncology drugs market is segmented by drug class type into
    • a) Chemotherapy
    • b) Targeted Therapy
    • c) Immunotherapy (Biologic Therapy)
    • d) Hormonal Therapy
The targeted therapy was the largest segment of the oncology drugs market by drug class type, accounting for 43.1% of the total market in 2020. Going forward, the chemotherapy segment is expected to be the fastest growing segment in the oncology drugs market, at a CAGR of 13.3%.
By Distribution Channel –
The oncology drugs market is segmented by distribution channel into
    • a) Hospital Pharmacies
    • b) Retail Pharmacies/Drug Stores
    • c) Others
The hospital pharmacies was the largest segment of the oncology drugs market by distribution channel, accounting for 51.2% of the total market in 2020. Going forward, the hospital pharmacies segment is expected to be the fastest growing segment in the oncology drugs market, at a CAGR of 9.7%.
By Route Of Administration –
The oncology drugs market is segmented by route of administration into
    • a) Oral
    • b) Parenteral
    • c) Others
The parental was the largest segment of the oncology drugs market by route of administration, accounting for 52.7% of the total market in 2020. Going forward, the others segment is expected to be the fastest growing segment in the oncology drugs market, at a CAGR of 12.7%.
By Drug Classification –
The oncology drugs market is segmented by drug classification into
    • a) Branded Drugs
    • b) Generic Drugs
The branded drugs was the largest segment of the oncology drugs market by drug classification, accounting for 94.2% of the total market in 2020. Going forward, the generic drugs segment is expected to be the fastest growing segment in the oncology drugs market, at a CAGR of 11.6%.
By Geography –
The oncology drugs market is segmented by geography into
      o Asia Pacific
      • • China
      • • Australia
      • • Hong Kong
      • • India
      • • Indonesia
      • • Japan
      • • Malaysia
      • • New Zealand
      • • Philippines
      • • Singapore
      • • South Korea
      • • Thailand
      • • Vietnam
      o North America
      • • Canada
      • • Mexico
      • • USA
      o South America
      • • Argentina
      • • Brazil
      • • Chile
      • • Colombia
      • • Peru
      • • Venezuela
      o Western Europe
      • • Austria
      • • Belgium
      • • Denmark
      • • Finland
      • • France
      • • Germany
      • • Ireland
      • • Italy
      • • Netherlands
      • • Norway
      • • Portugal
      • • Spain
      • • Sweden
      • • Switzerland
      • • UK
      o Eastern Europe
      • • Poland
      • • Romania
      • • Czech Republic
      • • Russia
      o Middle East
      • • Saudi Arabia
      • • Israel
      • • Turkey
      • • UAE
      o Africa
      • • Egypt
      • • Nigeria
      • • South Africa
North America was the largest region in the global oncology drugs market, accounting for 41.2% of the total in 2020. It was followed by the Asia Pacific, Western Europe, and then the other regions. Going forward, the fastest-growing regions in the oncology drugs market will be South America and Middle East, where growth will be at CAGRs of 12.7% and 10.8% respectively. These will be followed by North America and Eastern Europe, where the markets are expected to register CAGRs of 9.6% and 8.1% respectively.

Oncology Drugs Competitive Landscape

Major Competitors In The Oncology Drugs Market Are:

  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • Takeda Pharmaceuticals
  • Gilead Sciences Inc.
  • Bristol-Myers Squibb (Celgene)

    • Other Competitors In The Oncology Drugs Market Include:

  • Bayer AG
    • <
  • > Adcock Ingram
  • AdoRx Therapeutics
  • Amgen
  • Apikos Pharma
  • AQVIDA GmbH
  • Arlak Biotech
  • Aspen
  • Astellas Pharma Inc
  • AstraZeneca plc
  • Baxter International Inc.
  • BeiGene
  • Biocad
  • Cambridge Cancer Genomics
  • CARsgen Therapeutics
  • Catalyst Clinical Research
  • Celentyx
  • Celgene Corporation
  • Cellomatics BioSciences
  • Celnova Pharma
  • Celon Pharma
  • Chugai Pharmaceutical Co. Ltd
  • Clovis Oncology
  • CStone Pharma
  • Daiichi Pharmaceutical and Sankyo
  • Eisai
  • Eli Lilly and Company
  • Eurofarma Laboratórios S.A.
  • Eurolab
  • GlaxoSmithKline plc
  • Healthkind Labs Pvt Ltd
  • Johnson & Johnson
  • JW Therapeutics
  • Kolaz biotech
  • Kyowa Hakko Kirin
  • Merck
  • Mitsubishi Tanabe Pharma Corporation
  • Neopharma LLC
  • Otsuka Pharmaceutical Co., Ltd
  • Pfizer
  • Pharmacyclics
  • Pierre Fabre Group
  • Roche
  • Sandoz AG
  • Sanofi
  • Shionogi Co.Ltd.
  • Sumitomo Dainippon Pharma
  • SwisscheM Healthcare Pvt.Ltd
  • Teva Pharmaceutical Industries Ltd.
  • TUTEUR Argentina
  • Veropharm
  • Zahraa Oncology
  • Zuviuslifesciences

      • Table Of Contents

      Table 1: Global Organic Soft Drinks Market, Historic, 2015 – 2020, $ Million

      Table 2: Global Organic Soft Drinks Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 3: Global Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 4: Global Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 5: Global Organic Soft Drinks Market, Segmentation By Packaging, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 6: Global Organic Soft Drinks Market, Segmentation By Packaging, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 7: Global Organic Soft Drinks Market, Segmentation By Distribution, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 8: Global Organic Soft Drinks Market, Segmentation By Distribution, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 9: Global Organic Soft Drinks Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 10: Global Organic Soft Drinks Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 11: Global Organic Soft Drinks Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 12: Global Organic Soft Drinks Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 13:  Asia Pacific Population By Age Group, 2015-2025, Thousands

      Table 14: Asia-Pacific Organic Soft Drinks Market, Historic, 2015 – 2020, $ Million

      Table 15: Asia-Pacific Organic Soft Drinks Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 16: Asia-Pacific Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 17: Asia-Pacific Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 18: China GDP Per Capita, 2015-2020, $

      Table 19:  China Population By Age Group, 2015-2025, Thousands

      Table 20: China Organic Soft Drinks Market, Historic, 2015 – 2020, $ Million

      Table 21: China Organic Soft Drinks Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 22: China Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 23: China Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 24: India Organic Soft Drinks Market, Historic, 2015 – 2020, $ Million

      Table 25: India Organic Soft Drinks Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 26: India Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 27: India Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 28: Japan Organic Soft Drinks Market, Historic, 2015 – 2020, $ Million

      Table 29: Japan Organic Soft Drinks Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 30: Japan Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 31: Japan Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 32: Australia Organic Soft Drinks Market, Historic, 2015 – 2020, $ Million

      Table 33: Australia Organic Soft Drinks Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 34: Australia Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 35: Australia Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 36: Indonesia Organic Soft Drinks Market, Historic, 2015 – 2020, $ Million

      Table 37: Indonesia Organic Soft Drinks Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 38: Indonesia Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 39: Indonesia Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 40: South Korea Organic Soft Drinks Market, Historic, 2015 – 2020, $ Million

      Table 41: South Korea Organic Soft Drinks Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 42: South Korea Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 43: South Korea Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 44:  Western Europe Population By Age Group, 2015-2025, Thousands

      Table 45: Western Europe GDP Per Capita, 2015-2020, $

      Table 46: Western Europe Organic Soft Drinks Market, Historic, 2015 – 2020, $ Million

      Table 47: Western Europe Organic Soft Drinks Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 48: Western Europe Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 49: Western Europe Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 50: UK Organic Soft Drinks Market, Historic, 2015 – 2020, $ Million

      Table 51: UK Organic Soft Drinks Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 52: UK Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 53: UK Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 54: Germany Organic Soft Drinks Market, Historic, 2015 – 2020, $ Million

      Table 55: Germany Organic Soft Drinks Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 56: Germany Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 57: Germany Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 58: France Organic Soft Drinks Market, Historic, 2015 – 2020, $ Million

      Table 59: France Organic Soft Drinks Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 60: France Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 61: France Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 62:  Eastern Europe Population By Age Group, 2015-2025, Thousands

      Table 63: Eastern Europe GDP Per Capita, 2015-2020, $

      Table 64: Eastern Europe Organic Soft Drinks Market, Historic, 2015 – 2020, $ Million

      Table 65: Eastern Europe Organic Soft Drinks Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 66: Eastern Europe Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 67: Eastern Europe Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 68: Russia Organic Soft Drinks Market, Historic, 2015 – 2020, $ Million

      Table 69: Russia Organic Soft Drinks Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 70: Russia Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 71: Russia Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 72:  North America Population By Age Group, 2015-2025, Thousands

      Table 73: North America GDP Per Capita, 2015-2020, $

      Table 74: North America Organic Soft Drinks Market, Historic, 2015 – 2020, $ Million

      Table 75: North America Organic Soft Drinks Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 76: North America Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 77: North America Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 78:  USA Population By Age Group, 2015-2025, Thousands

      Table 79: USA GDP Per Capita, 2015-2020, $

      Table 80: USA Organic Soft Drinks Market, Historic, 2015 – 2020, $ Million

      Table 81: USA Organic Soft Drinks Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 82: USA Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 83: USA Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 84:  South America Population By Age Group, 2015-2025, Thousands

      Table 85: South America GDP Per Capita, 2015-2020, $

      Table 86: South America Organic Soft Drinks Market, Historic, 2015 – 2020, $ Million

      Table 87: South America Organic Soft Drinks Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 88: South America Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 89: South America Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 90: Brazil Organic Soft Drinks Market, Historic, 2015 – 2020, $ Million

      Table 91: Brazil Organic Soft Drinks Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 92: Brazil Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 93: Brazil Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 94:  Middle East Population By Age Group, 2015-2025, Thousands

      Table 95: Middle East GDP Per Capita, 2015-2020, $

      Table 96: Middle East Organic Soft Drinks Market, Historic, 2015 – 2020, $ Million

      Table 97: Middle East Organic Soft Drinks Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 98: Middle East Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 99: Middle East Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 100:  Africa Population By Age Group, 2015-2025, Thousands

      Table 101: Africa GDP Per Capita, 2015-2020, $

      Table 102: Africa Organic Soft Drinks Market, Historic, 2015 – 2020, $ Million

      Table 103: Africa Organic Soft Drinks Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 104: Africa Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 105: Africa Organic Soft Drinks Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 106: Global Organic Soft Drinks Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)

      Table 107: Hain Celestial Group – Financial Performance, 2015 – 2019, $ Billion

      Table 108: Global Organic Soft Drinks Market Size Gain ($ Million), 2020 – 2025, By Country

      Table 109: Global Organic Soft Drinks Market Size Gain ($ Million), Segmentation By Product Type, 2020 – 2025

      Table 110: Global Organic Soft Drinks Market Size Gain ($ Million), Segmentation By Distribution, 2020 – 2025

      Table 111: Global Organic Soft Drinks Market Size Gain ($ Million), Segmentation By Packaging, 2020 – 2025

      Table 112: Organic Soft Drinks - Market Data Sources

    List Of Tables

      Table 1: Global Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 2: Global Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 3: Global Oncology Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 4: Global Oncology Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 5: Global Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
    • Table 6: Global Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Region
    • Table 7: Global Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 8: Global Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 9: Global Oncology Drugs Market, Segmentation By Drug Class Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 10: Global Oncology Drugs Market, Segmentation By Drug Class Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 11: Global Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 12: Global Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 13: Global Oncology Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 14: Global Oncology Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 15: Global Oncology Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 16: Global Oncology Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 17: Global Oncology Drugs Market Value, Market Size As A Percentage Of Global GDP, 2015 – 2025
    • Table 18: Global Oncology Drugs Market, Per Capita Average Oncology Drugs Market Industry Expenditure, 2015 – 2025, ($)
    • Table 19: Asia Pacific, GDP Per Capita, 2015-2020, $
    • Table 20: Asia-Pacific, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 21: Asia Pacific, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 22: Asia-Pacific, Healthcare Services Market Size, By Country, 2015-2019, $ Billion
    • Table 23: Asia-Pacific Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 24: Asia-Pacific Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 25: Asia-Pacific Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 26: Asia-Pacific Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 27: Asia-Pacific Oncology Drugs Market, 2020, By Country, Value ($ Million)
    • Table 28: Asia-Pacific Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 29: Asia-Pacific Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 30: Asia-Pacific Per Capita Oncology Drugs Expenditure, By Country, 2020, $
    • Table 31: China, GDP Per Capita, 2015-2020, $
    • Table 32: China, Per Capita Healthcare Expenditure, 2015-2019, $
    • Table 33: China, Population By Age Group, 2015-2023, Thousands
    • Table 34: China, Healthcare Services Market Size, 2015-2019, $ Billion
    • Table 35: China Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 36: China Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 37: China Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 38: China Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 39: Australia Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 40: Australia Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 41: Australia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 42: Australia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 43: Hong Kong Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 44: Hong Kong Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 45: India GDP Per Capita, 2015-2020, $
    • Table 46: India, Per Capita Healthcare Expenditure, 2015-2019, $
    • Table 47: India, Population By Age Group, 2015-2023, Thousands
    • Table 48: India, Healthcare Services Market Size, 2015-2019, $ Billion
    • Table 49: India Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 50: India Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 51: India Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 52: India Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 53: Indonesia Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 54: Indonesia Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 55: Indonesia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 56: Indonesia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 57: Japan GDP Per Capita, 2015-2020, $
    • Table 58: Japan, Per Capita Healthcare Expenditure, 2015-2019, $
    • Table 59: Japan, Population By Age Group, 2015-2023, Thousands
    • Table 60: Japan, Healthcare Services Market Size, 2015-2019, $ Billion
    • Table 61: Japan Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 62: Japan Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 63: Japan Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 64: Japan Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 65: Malaysia Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 66: Malaysia Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 67: New Zealand Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 68: New Zealand Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 69: Philippines Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 70: Philippines Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 71: Singapore Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 72: Singapore Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 73: South Korea Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 74: South Korea Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 75: South Korea Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 76: South Korea Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 77: Thailand Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 78: Thailand Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 79: Vietnam Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 80: Vietnam Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 81: Western Europe, GDP Per Capita, 2015-2020, $
    • Table 82: Western Europe, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 83: Western Europe, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 84: Western Europe, Healthcare Services Market Size, By Country, 2015-2019, $ Billion
    • Table 85: Western Europe Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 86: Western Europe Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 87: Western Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 88: Western Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 89: Western Europe Oncology Drugs Market, 2020, By Country, Value ($ Million)
    • Table 90: Western Europe Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 91: Western Europe Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 92: Western Europe Per Capita Oncology Drugs Expenditure, By Country, 2020, $
    • Table 93: Austria Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 94: Austria Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 95: Belgium Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 96: Belgium Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 97: Denmark Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 98: Denmark Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 99: Finland Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 100: Finland Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 101: France Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 102: France Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 103: France Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 104: France Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 105: Germany Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 106: Germany Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 107: Germany Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 108: Germany Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 109: Ireland Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 110: Ireland Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 111: Italy Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 112: Italy Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 113: Netherlands Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 114: Netherlands Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 115: Norway Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 116: Norway Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 117: Portugal Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 118: Portugal Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 119: Spain Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 120: Spain Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 121: Sweden Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 122: Sweden Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 123: Switzerland Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 124: Switzerland Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 125: UK GDP Per Capita, 2015-2020, $
    • Table 126: UK, Per Capita Healthcare Expenditure, 2015-2019, $
    • Table 127: UK, Population By Age Group, 2015-2023, Thousands
    • Table 128: UK, Healthcare Services Market Size, 2015-2019, $ Billion
    • Table 129: UK Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 130: UK Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 131: UK Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 132: UK Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 133: Eastern Europe GDP Per Capita, 2015-2020, $
    • Table 134: Eastern Europe Oncology Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 135: Eastern Europe Oncology Drugs Market, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 136: Eastern Europe Oncology Drugs Market, Healthcare Services Market Size, By Country, 2015-2019, $ Billion
    • Table 137: Eastern Europe Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 138: Eastern Europe Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 139: Eastern Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 140: Eastern Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 141: Eastern Europe Oncology Drugs Market, 2020, By Country, Value ($ Million)
    • Table 142: Eastern Europe Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 143: Eastern Europe Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 144: Eastern Europe Per Capita Oncology Drugs Expenditure, By Country, 2020, $
    • Table 145: Czech Republic Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 146: Czech Republic Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 147: Poland Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 148: Poland Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 149: Romania Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 150: Romania Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 151: Russia Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 152: Russia Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 153: Russia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 154: Russia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 155: North America GDP Per Capita, 2015-2020, $
    • Table 156: North America, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 157: North America, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 158: North America, Healthcare Services Market Size, By Country, 2015-2019, $ Billion
    • Table 159: North America Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 160: North America Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 161: North America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 162: North America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 163: North America Oncology Drugs Market, 2020, By Country, Value ($ Million)
    • Table 164: North America Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 165: North America Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 166: North America Per Capita Oncology Drugs Expenditure, By Country, 2020, $
    • Table 167: Canada Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 168: Canada Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 169: Mexico Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 170: Mexico Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 171: USA GDP Per Capita, 2015-2020, $
    • Table 172: USA, Per Capita Healthcare Expenditure, 2015-2019, $
    • Table 173: USA, Population By Age Group, 2015-2023, Thousands
    • Table 174: USA, Healthcare Services Market Size, 2015-2019, $ Billion
    • Table 175: USA Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 176: USA Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 177: USA Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 178: USA Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 179: South America GDP Per Capita, 2015-2020, $
    • Table 180: South America, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 181: South America, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 182: South America, Healthcare Services Market Size, By Country, 2015-2019, $ Billion
    • Table 183: South America Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 184: South America Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 185: South America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 186: South America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 187: South America Oncology Drugs Market, 2020, By Country, Value ($ Million)
    • Table 188: South America Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 189: South America Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 190: South America Per Capita Oncology Drugs Expenditure, By Country, 2020, $
    • Table 191: Argentina Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 192: Argentina Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 193: Brazil Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 194: Brazil Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 195: Brazil Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 196: Brazil Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 197: Chile Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 198: Chile Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 199: Colombia Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 200: Colombia Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 201: Peru Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 202: Peru Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 203: Venezuela Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 204: Venezuela Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 205: Middle East GDP Per Capita, 2015-2020, $
    • Table 206: Middle East, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 207: Middle East, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 208: Middle East Oncology Drugs Market, Healthcare Services Market Size, By Country, 2015-2019, $ Billion
    • Table 209: Middle East Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 210: Middle East Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 211: Middle East Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 212: Middle East Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 213: Middle East Oncology Drugs Market, 2020, By Country, Value ($ Million)
    • Table 214: Middle East Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 215: Middle East Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 216: Middle East Per Capita Oncology Drugs Expenditure, By Country, 2020, $
    • Table 217: Saudi Arabia Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 218: Saudi Arabia Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 219: Israel Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 220: Israel Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 221: Turkey Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 222: Turkey Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 223: UAE Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 224: UAE Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 225: Africa GDP Per Capita, 2015-2020, $
    • Table 226: Africa, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 227: Africa, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 228: Africa, Healthcare Services Market Size, By Country, 2015-2019, $ Billion
    • Table 229: Africa Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 230: Africa Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 231: Africa Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 232: Africa Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 233: Africa Oncology Drugs Market, 2020, By Country, Value ($ Million)
    • Table 234: Africa Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 235: Africa Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 236: Middle East Per Capita Oncology Drugs Expenditure, By Country, 2020, $
    • Table 237: Egypt Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 238: Egypt Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 239: Nigeria Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 240: Nigeria Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 241: South Africa Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 242: South Africa Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 243: Global Oncology Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Table 244: Bristol-Myers Squibb Company –  Financial Performance, 2016 – 2020, $ Billion
    • Table 245: F. Hoffmann-La Roche AG – Financial Performance, 2016 – 2020, $ Billion
    • Table 246: Merck & Co., Inc. – Financial Performance, 2016 - 2020, $ Billion
    • Table 247: Novartis AG – Financial Performance, 2016 – 2020, $ Billion
    • Table 248: Johnson & Johnson (J&J) – Financial Performance, 2016 – 2020, $ Billion
    • Table 249: Global Pharmaceutical Drugs Market, Segmentation By Type, 2015 – 2025, $ Billion
    • Table 250: Global Pharmaceutical Drugs Market, 2020, Split By Region
    • Table 251: Global Pharmaceutical Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
    • Table 252: Global Oncology Drugs Market Size Gain ($ Million), 2020 – 2025, By Country
    • Table 253: Global Oncology Drugs Market Size Gain ($ Million), Segmentation By Type, 2020 – 2025
    • Table 254: Global Oncology Drugs Market Size Gain ($ Million), Segmentation By Distribution Channel, 2020 – 2025
    • Table 255: Global Oncology Drugs Market Size Gain ($ Million), Segmentation By Route Of Administration, 2020 – 2025
    • Table 256: Global Oncology Drugs Market Size Gain ($ Million), Segmentation By Drug Classification, 2020 – 2025
    • Table 257: Global Oncology Drugs Market Size Gain ($ Million), Segmentation By Mode Of Purchase, 2020 – 2025

    List Of Figures

      Figure 1: Global Oncology Drugs Market Segmentation By Type
    • Figure 2: Global Oncology Drugs Market Segmentation By Drug Class Type
    • Figure 3: Global Oncology Drugs Market Segmentation By Distribution Channel
    • Figure 4: Global Oncology Drugs Market Segmentation By Route Of Administration
    • Figure 5: Global Oncology Drugs Market Segmentation By Drug Classification
    • Figure 6: Market Supply Chain For Oncology Drugs
    • Figure 7: Global Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 8: Global Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 9: Global Oncology Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 10: Global Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
    • Figure 11: Global Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Region
    • Figure 12: Global Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 13: Global Oncology Drugs Market, Segmentation By Drug Class Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 14: Global Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 15: Global Oncology Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 16: Global Oncology Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 17: Asia-Pacific Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 18: Asia-Pacific Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 19: Asia-Pacific Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 20: Asia-Pacific Oncology Drugs Market, 2020, By Country, Value ($ Million)
    • Figure 21: Asia-Pacific Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 22: Asia-Pacific Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 23: China Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 24: China Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 25: China Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 26: Australia Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 27: Australia Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 28: Australia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 29: Hong Kong Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 30: Hong Kong Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 31: India Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 32: India Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 33: India Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 34: Indonesia Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 35: Indonesia Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 36: Indonesia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 37: Japan Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 38: Japan Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 39: Japan Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 40: Malaysia Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 41: Malaysia Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 42: New Zealand Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 43: New Zealand Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 44: Philippines Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 45: Philippines Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 46: Singapore Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 47: Singapore Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 48: South Korea Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 49: South Korea Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 50: South Korea Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 51: Thailand Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 52: Thailand Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 53: Vietnam Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 54: Vietnam Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 55: Western Europe Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 56: Western Europe Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 57: Western Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 58: Western Europe Oncology Drugs Market, 2020, By Country, Value ($ Million)
    • Figure 59: Western Europe Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 60: Western Europe Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 61: Austria Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 62: Austria Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 63: Belgium Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 64: Belgium Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 65: Denmark Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 66: Denmark Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 67: Finland Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 68: Finland Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 69: France Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 70: France Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 71: France Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 72: Germany Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 73: Germany Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 74: Germany Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 75: Ireland Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 76: Ireland Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 77: Italy Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 78: Italy Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 79: Netherlands Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 80: Netherlands Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 81: Norway Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 82: Norway Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 83: Portugal Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 84: Portugal Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 85: Spain Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 86: Spain Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 87: Sweden Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 88: Sweden Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 89: Switzerland Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 90: Switzerland Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 91: UK Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 92: UK Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 93: UK Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 94: Eastern Europe Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 95: Eastern Europe Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 96: Eastern Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 97: Eastern Europe Oncology Drugs Market, 2020, By Country, Value ($ Million)
    • Figure 98: Eastern Europe Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 99: Eastern Europe Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 100: Czech Republic Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 101: Czech Republic Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 102: Poland Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 103: Poland Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 104: Romania Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 105: Romania Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 106: Russia Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 107: Russia Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 108: Russia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 109: North America Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 110: North America Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 111: North America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 112: North America Oncology Drugs Market, 2020, By Country, Value ($ Million)
    • Figure 113: North America Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 114: North America Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 115: Canada Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 116: Canada Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 117: Mexico Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 118: Mexico Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 119: USA Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 120: USA Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 121: USA Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 122: South America Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 123: South America Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 124: South America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 125: South America Oncology Drugs Market, 2020, By Country, Value ($ Million)
    • Figure 126: South America Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 127: South America Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 128: Argentina Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 129: Argentina Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 130: Brazil Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 131: Brazil Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 132: Brazil Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 133: Chile Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 134: Chile Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 135: Colombia Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 136: Colombia Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 137: Peru Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 138: Peru Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 139: Venezuela Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 140: Venezuela Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 141: Middle East Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 142: Middle East Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 143: Middle East Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 144: Middle East Oncology Drugs Market, 2020, By Country, Value ($ Million)
    • Figure 145: Middle East Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 146: Middle East Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 147: Saudi Arabia Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 148: Saudi Arabia Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 149: Israel Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 150: Israel Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 151: Turkey Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 152: Turkey Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 153: UAE Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 154: UAE Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 155: Africa Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 156: Africa Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 157: Africa Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 158: Africa Oncology Drugs Market, 2020, By Country, Value ($ Million)
    • Figure 159: Africa Oncology Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 160: Africa Oncology Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 161: Egypt Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 162: Egypt Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 163: Nigeria Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 164: Nigeria Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 165: South Africa Oncology Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 166: South Africa Oncology Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 167: Global Oncology Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Figure 168 Bristol-Myers Squibb Company – Financial Performance, 2016 – 2020, $ Billion
    • Figure 169: F. Hoffmann-La Roche AG – Financial Performance, 2016 – 2020, $ Billion
    • Figure 170: Merck & Co., Inc. – Financial Performance, 2016-2020, $ Billion
    • Figure 171: Novartis AG – Financial Performance, 2016 – 2020, $ Billion
    • Figure 172: Johnson & Johnson (J&J) – Financial Performance, 2016 – 2020, $ Billion
    • Figure 173: Global Pharmaceutical Drugs Market, Segmentation By Type, 2015 – 2025, $ Billion
    • Figure 174: Global Pharmaceutical Drugs Market, 2020, Split By Region
    • Figure 175: Global Pharmaceutical Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
    Global Anti-Infective Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Read More
    Global Cell and Gene Therapy Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Read More
    Global Pharmaceutical Drugs And Biologics Logistics Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Read More
    Global Pharmaceutical Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Read More
    Global Microbiome Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Read More
    Global G-CSF (Granulocyte Colony Stimulating Factors) Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Read More
    Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Read More
    Global Therapeutic Proteins Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Read More
    Cancer Vaccines Global Market Report 2021 - By Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), By Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines), By Cancer Type (Prostate, Cervical, Colorectal, Throat), By End-User (Cancer Treatment Centers, Research Institutes), COVID-19 Growth And Change
    View Report
    Cancer Monoclonal Antibodies Global Market Report 2021 - By Monoclonal Antibody Therapies (Bevacizumab (Avastin), Rituximab (Rituxan), Trastuzumab (Herceptin), Cetuximab (Erbitux), Panitumumab (Vectibix)), By Application (Breast Cancer, Blood Cancer, Liver Cancer, Brain Cancer, Colorectal Cancer), By End User (Hospitals And Clinics, Research Laboratories, Pharmacies), COVID-19 Growth And Change
    View Report
    Cancer Clinical Decision Tools Global Market Report 2021 - By Type (Risk Assessment Tool (RAT), Qcancer), By End-User (Hospital, Clinics), COVID-19 Growth And Change
    View Report
    Cancer Biologics Global Market Report 2021 - By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy), By Application (Hospitals, Clinics), COVID-19 Growth And Change
    View Report
    Cancer Diagnostics Global Market Report 2021 - By Products (Companion Diagnostics, Molecular Diagnostics), By End-User (Cancer Research Institutes, Diagnostic Laboratories, Hospitals), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma), COVID-19 Growth And Change
    View Report
    Drugs For Hormonal Replacement Therapy Global Market Report 2021 - By Therapy Type (Estrogen Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, Menopause), By Route of Administration (Oral, Parental), COVID-19 Impact and Recovery
    View Report
    Antibody Drug Conjugates Global Market Report 2021 - By Type (Monoclonal Antibodies, Linker, Drug/Toxin), By Application (Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumor), By Product (Adcertis, Kadcyla), By Technology (Immunogen Technology, Seattle Genetics Technology, Immunomedics Technology), By End User (Hospital, Clinics), COVID-19 Growth And Change
    View Report
    Cell And Gene Therapy Global Market Report 2021 - By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Dermatology, Musculoskeletal), By End User (Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers), COVID-19 Growth And Change
    View Report

    Call Us

    +1 3156230293

    (Americas)

    +44 2071930708

    (Europe)

    +91 8897263534

    (Asia & Others)